Other News To Note
• Lorus Therapeutics Inc., of Toronto, signed a collaboration agreement with Brock University of St. Catherines, Ontario, for the development of cancer drugs based on chemical derivatives of the natural compound pancratistatin.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5476
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST